PanGen Biotech Inc. (KOSDAQ:222110)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,980.00
-60.00 (-0.99%)
At close: Aug 28, 2025

PanGen Biotech Income Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Operating Revenue
15,85714,6737,3156,5017,9366,191
Upgrade
Other Revenue
-0-0-0---
Upgrade
15,85714,6737,3156,5017,9366,191
Upgrade
Revenue Growth (YoY)
42.45%100.58%12.53%-18.08%28.18%114.87%
Upgrade
Cost of Revenue
9,4399,5346,3435,8587,4204,838
Upgrade
Gross Profit
6,4185,139971.8642.47515.691,353
Upgrade
Selling, General & Admin
1,7371,7681,5361,272969.851,108
Upgrade
Research & Development
1,7442,0123,3323,8502,7343,676
Upgrade
Other Operating Expenses
28.9426.3226.6425.922834.25
Upgrade
Operating Expenses
3,8294,1185,1975,2333,8045,053
Upgrade
Operating Income
2,5891,020-4,225-4,591-3,288-3,700
Upgrade
Interest Expense
-218.5-322.1-220.68-128.77-293.25-1,013
Upgrade
Interest & Investment Income
332.01184.7841.75246.57179.7255.54
Upgrade
Currency Exchange Gain (Loss)
-39.01172.7912.477.3492.88-83.99
Upgrade
Other Non Operating Income (Expenses)
-336.16-91.66-64.637.9759.88185.79
Upgrade
EBT Excluding Unusual Items
2,328963.97-4,457-4,428-3,249-4,356
Upgrade
Gain (Loss) on Sale of Assets
17.2513.7715.15-0.24-0.67-0.03
Upgrade
Other Unusual Items
25.8525.85--7.39--
Upgrade
Pretax Income
2,3711,004-4,441-4,435-3,250-4,356
Upgrade
Income Tax Expense
73.5359.947.4358.6960.5-
Upgrade
Net Income
2,297943.69-4,489-4,494-3,310-4,356
Upgrade
Net Income to Common
2,297943.69-4,489-4,494-3,310-4,356
Upgrade
Shares Outstanding (Basic)
121111111010
Upgrade
Shares Outstanding (Diluted)
121111111010
Upgrade
Shares Change (YoY)
13.67%7.03%0.13%4.47%6.02%-0.04%
Upgrade
EPS (Basic)
185.1582.49-420.00-421.00-324.00-452.00
Upgrade
EPS (Diluted)
185.1582.49-420.00-421.00-324.00-452.00
Upgrade
Free Cash Flow
4,1912,627-3,873-4,231-4,749-5,437
Upgrade
Free Cash Flow Per Share
337.73229.63-362.36-396.34-464.83-564.12
Upgrade
Gross Margin
40.48%35.02%13.29%9.88%6.50%21.86%
Upgrade
Operating Margin
16.33%6.95%-57.76%-70.62%-41.44%-59.77%
Upgrade
Profit Margin
14.49%6.43%-61.36%-69.13%-41.72%-70.36%
Upgrade
Free Cash Flow Margin
26.43%17.90%-52.94%-65.08%-59.85%-87.81%
Upgrade
EBITDA
4,0492,489-2,629-2,987-1,756-2,132
Upgrade
EBITDA Margin
25.53%16.96%-35.94%-45.96%-22.13%-34.44%
Upgrade
D&A For EBITDA
1,4591,4681,5971,6031,5321,568
Upgrade
EBIT
2,5891,020-4,225-4,591-3,288-3,700
Upgrade
EBIT Margin
16.33%6.95%-57.76%-70.62%-41.44%-59.77%
Upgrade
Effective Tax Rate
3.10%5.97%----
Upgrade
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.